Taking Aim At Advanced Therapies
VC Playbook: 4BIO Executives Discuss Targets For The Investment Firm’s New Fund
Executive Summary
Dmitry Kuzmin, managing partner, and Owen Smith, investment director, talk to In Vivo about 4BIO’s approach to venture investing in the biopharma sector: successes, red flags and targets for its second fund.